Please login to the form below

Not currently logged in
Email:
Password:

Covington boosts European life sciences group

New partner and an associate will focus on issues involving EU law

Adem Koyuncu, CovingtonLegal firm Covington & Burling has added a new partner and an associate to strengthen its efforts in EU law for life sciences companies.

New partner Dr Adem Koyuncu (pictured) is qualified as both a lawyer and medical doctor, and will join Covington's compliance practice, heading the firm's German life sciences practice.

A leading life sciences lawyer, he has worked on EU and German regulatory issues concerned with pharmaceuticals, medical devices and other health and consumer products.

Koyuncu has also worked in compliance, privacy and product liability matters, along with assisting life sciences clients with corporate transactions. He joins Covington from another international law firm, where he was partner and co-chair of the global life sciences group.

Covington's Brussels office serves as a hub for EU clients, and the firm hopes that appointing Koyuncu will enhance its ability to advise a broad range of clients across German and the wider European Union.

"Dr Koyuncu's arrival significantly strengthens our ability to advise a broad range of clients in the pharmaceuticals and medical devices industries on matters in Germany, the EU and Europe,” said Covington chairman Timothy Hester.

Joining Covington alongside Koyuncu is new associate Sabine Stute, who is also licensed to practice law in Germany. Both will be based in Brussels.

7th January 2014

From: Sales, Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics